x

Mersana Therapeutics, Inc. (Nasdaq:MRSN)

Health Care/Life Sciences • Biotechnology
CIK 1442836
Company

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.

Address
840 Memorial Drive
Cambridge, Massachusetts 02139
Employees
123
Stock Info
Close
$5.77
Day Range
5.56 - 5.89
52 Week Range
0.80 - 9.62
Average volume
2.25M
Short Interest
7.1M (02/15/24)
% of Float Shorted
7.73%
Market Cap
$697.49M
Revenue
$36.86M
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
$299.63K
P/E Ratio
N/A
EPS
-$1.50
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Martin H Huber MD
Director
Anna Protopapas MBA
Chairman
David M Mott
Independent Director
Allene M Diaz
Independent Director
Willard H Dere MD
Independent Director
Kristen M Hege MD
Independent Director
Lawrence M Alleva EMBA, CPA
Independent Director
Andrew A. F Hack MD, PhD
SEC filings
DateFormEvent
13 Aug, 2024 10-Q
13 Aug, 2024 8-K
2 Jul, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
11 Jun, 2024 8-K
17 May, 2024 SC 13G
9 May, 2024 8-K
9 May, 2024 EFFECT
9 May, 2024 10-Q
9 May, 2024 424B5
26 Apr, 2024 DEF 14A
26 Apr, 2024 DEFA14A
26 Apr, 2024 ARS
3 Apr, 2024 4
28 Feb, 2024 10-K
28 Feb, 2024 424B5
28 Feb, 2024 8-K
28 Feb, 2024 8-K
28 Feb, 2024 POSASR
28 Feb, 2024 POS AM
16 Feb, 2024 4/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
13 Feb, 2024 SC 13G
29 Jan, 2024 SC 13G/A
22 Jan, 2024 SC 13G/A
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
16 Jan, 2024 144
16 Jan, 2024 144
16 Jan, 2024 144
16 Jan, 2024 144
12 Jan, 2024 S-8
5 Jan, 2024 8-K
4 Jan, 2024 4
4 Jan, 2024 4
4 Jan, 2024 4
4 Jan, 2024 4
21 Dec, 2023 8-K
7 Nov, 2023 10-Q
7 Nov, 2023 8-K
31 Oct, 2023 8-K
27 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
13 Sep, 2023 4
13 Sep, 2023 4
12 Sep, 2023 8-K
7 Sep, 2023 4
7 Sep, 2023 3
7 Sep, 2023 4
7 Sep, 2023 4
7 Sep, 2023 4
7 Sep, 2023 4
6 Sep, 2023 8-K CEO Change
18 Aug, 2023 4
8 Aug, 2023 8-K
8 Aug, 2023 10-Q
7 Aug, 2023 SC 13G
31 Jul, 2023 3
27 Jul, 2023 8-K
27 Jul, 2023 SC 13G
6 Jul, 2023 4
6 Jul, 2023 4
6 Jul, 2023 4
6 Jul, 2023 4
6 Jul, 2023 4
15 Jun, 2023 8-K
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
9 Jun, 2023 8-K
9 May, 2023 10-Q
9 May, 2023 S-3ASR
9 May, 2023 8-K
28 Apr, 2023 ARS
28 Apr, 2023 DEFA14A
28 Apr, 2023 4
28 Apr, 2023 DEF 14A
14 Apr, 2023 PRE 14A
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
31 Mar, 2023 8-K
24 Mar, 2023 8-K
13 Mar, 2023 8-K
28 Feb, 2023 8-K
28 Feb, 2023 10-K
28 Feb, 2023 S-8
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G/A
6 Feb, 2023 SC 13G/A
3 Feb, 2023 SC 13G/A
1 Feb, 2023 8-K
31 Jan, 2023 SC 13G/A
25 Jan, 2023 8-K
19 Jan, 2023 SC 13G/A
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
6 Jan, 2023 8-K
27 Dec, 2022 8-K
22 Dec, 2022 8-K
16 Dec, 2022 4
2 Dec, 2022 4
7 Nov, 2022 8-K
7 Nov, 2022 424B5
7 Nov, 2022 8-K
7 Nov, 2022 10-Q
6 Oct, 2022 8-K
18 Aug, 2022 4
16 Aug, 2022 8-K
8 Aug, 2022 10-Q
8 Aug, 2022 8-K
8 Aug, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 8-K
2 Jun, 2022 4
26 May, 2022 4
23 May, 2022 4
18 May, 2022 4
11 May, 2022 SC 13D/A
9 May, 2022 8-K
9 May, 2022 10-Q
29 Apr, 2022 DEF 14A
29 Apr, 2022 DEFA14A
28 Apr, 2022 4
18 Apr, 2022 PRE 14A
14 Apr, 2022 4
14 Apr, 2022 SC 13D/A
13 Apr, 2022 4
28 Feb, 2022 S-8
28 Feb, 2022 8-K
28 Feb, 2022 8-K
28 Feb, 2022 424B5
28 Feb, 2022 10-K
17 Feb, 2022 SC 13G
11 Feb, 2022 SC 13G
10 Feb, 2022 SC 13G
8 Feb, 2022 4
8 Feb, 2022 SC 13D/A
4 Feb, 2022 SC 13G/A
3 Feb, 2022 8-K
27 Jan, 2022 SC 13G
26 Jan, 2022 SC 13G/A
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
4 Jan, 2022 4
3 Jan, 2022 4
3 Jan, 2022 SC 13D/A
20 Dec, 2021 4
2 Dec, 2021 4
23 Nov, 2021 8-K
18 Nov, 2021 EFFECT
16 Nov, 2021 CORRESP
15 Nov, 2021 UPLOAD
9 Nov, 2021 S-3
9 Nov, 2021 8-K
9 Nov, 2021 10-Q
29 Oct, 2021 8-K
16 Sep, 2021 SC 13G
10 Sep, 2021 8-K
24 Aug, 2021 4
18 Aug, 2021 4
18 Aug, 2021 3
16 Aug, 2021 8-K
6 Aug, 2021 8-K
6 Aug, 2021 10-Q
22 Jul, 2021 4
19 Jul, 2021 4
19 Jul, 2021 4
19 Jul, 2021 4
9 Jul, 2021 4
2 Jul, 2021 4
2 Jul, 2021 4
23 Jun, 2021 4
17 Jun, 2021 8-K
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
3 Jun, 2021 4
24 May, 2021 4
10 May, 2021 S-8
10 May, 2021 10-Q
10 May, 2021 8-K
28 Apr, 2021 4
28 Apr, 2021 3
27 Apr, 2021 DEFA14A
27 Apr, 2021 DEF 14A
22 Apr, 2021 4
9 Apr, 2021 8-K
24 Mar, 2021 4
11 Mar, 2021 3
11 Mar, 2021 4
11 Mar, 2021 8-K
26 Feb, 2021 8-K
26 Feb, 2021 10-K
24 Feb, 2021 4
12 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G
11 Feb, 2021 SC 13G/A
4 Feb, 2021 SC 13G
27 Jan, 2021 SC 13G/A
25 Jan, 2021 SC 13G
22 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
12 Jan, 2021 4
12 Jan, 2021 SC 13D/A
6 Jan, 2021 4
5 Jan, 2021 8-K
Last update:2024-03-06 12:18:49.609202
Mersana Therapeutics, Inc. by TradingView

Sign Up to Subscribe